Momenta Pharmaceuticals, Inc. (OQ:MNTA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for MNTA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 1,425  
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 2,363  
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock S - Open market or private sale -12,143 $33.31
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock S - Open market or private sale -2,363 $33.55
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock S - Open market or private sale -1,425 $33.55
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,425 $18.85
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,363 $10.83
Feb 20/20 Feb 19/20 Beltramello Jo Ann Direct Ownership Common Stock S - Open market or private sale -591 $33.45
Feb 20/20 Feb 18/20 Beltramello Jo Ann Direct Ownership Common Stock S - Open market or private sale -13,750 $32.89
Feb 20/20 Feb 18/20 Manning Anthony M. Direct Ownership Common Stock S - Open market or private sale -16,459 $32.56
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MNTA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 1,425  
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 2,363  
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock S - Open market or private sale -12,143 $33.31
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock S - Open market or private sale -2,363 $33.55
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock S - Open market or private sale -1,425 $33.55
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,425 $18.85
Feb 24/20 Feb 20/20 Fier Ian Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,363 $10.83
Feb 20/20 Feb 19/20 Beltramello Jo Ann Direct Ownership Common Stock S - Open market or private sale -591 $33.45
Feb 20/20 Feb 18/20 Beltramello Jo Ann Direct Ownership Common Stock S - Open market or private sale -13,750 $32.89
Feb 20/20 Feb 18/20 Manning Anthony M. Direct Ownership Common Stock S - Open market or private sale -16,459 $32.56
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MNTA

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)